Ardelyx reported $-11872000 in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Abbott USD 3.05B 870M Jun/2025
Amgen USD 3.6B 147M Jun/2025
Ardelyx USD -11872000 20.51M Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Life Technologies USD -259000 15.39M Jun/2025
Sanofi EUR 1.89B 1.33B Jun/2025
TG Therapeutics USD 12.28M 17.68M Mar/2025
United Therapeutics USD 436.8M 34.2M Jun/2025